cerrar
Tagged with access,

Size Matters Less in Slovakia
Pharma companies in Slovakia are managing to circumvent the problems inherent in the size of the local market by focusing on the country’s…

Christophe Bourdon – SVP EMEA, Alexion Pharmaceuticals
Specializing in ultra-rare diseases, Alexion targets patient populations of less than 20 patients per million. Christophe Bourdon discusses…

Interview: Elena Strapkova Boydova – Country Director,…
Biogen Slovakia's Country Director on being an innovative global biotech in Slovakia, market access in the country, and the company's commitment to…

Interview: Alvaro Angel – General Manager, Bayer…
Alvaro Angel, the recently appointed general manager of the pharmaceutical division of Bayer Mexico, provides insights into the rapidly evolving local…

Interview: Svatopluk Betina – Country Manager, Lundbeck…
Lundbeck Slovakia Country Manager, Svatopluk Betina, reflects on the performance of one of the most innovative pharmaceutical firms in the region and…

Interview: Leonard Sojka – Managing Director, Merck…
Dr. Leonard Sojka who has spent over 25 years with the innovation-driven Merck group explains how Merck is turning its focus to science and…

Natasa Klicko – General Manager, Roche Slovakia
Dr. Natasa Klicko, General Manager of Roche Slovakia, outlines the challenges and opportunities for the company in the country; their strategy of…

Interview: Reginald Decraene – Managing Director, Pfizer…
The recently appointed managing director of Pfizer Luxembourg discusses the current footprint of the company in the country; how every affiliate…

Interview: Dr. Oliver Bleck – General Manager, Roche…
As the home market, Switzerland and Roche’s Swiss pharma operations play an important and pioneering role within Roche’s global organization, with…

Interview: Rodrigo Puga – Country Manager, Pfizer Mexico
Rodrigo Puga, the recently appointed general manager of Pfizer Mexico, documents his strategic priorities to further strengthen the company’s…

Interview: Ronald Scott – CEO, Basilea, Switzerland
Ronald Scott, CEO of Basilea, a biotech company that was spun out of Roche in 2000, talks about launching its first two products, Zevtera and…

Interview: Corina Croitoru – Country Manager, Gedeon Richter…
Corina Croitoru of Gedeon Richter Slovakia discusses GR’s footprint in the country, the affiliate’s main growth drivers, the importance of…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here